Insights

In this podcast, Dr Lea Ann Chen explains how race/ ethnicity (White, Black, Hispanic, Asian) and immigration status (US-born vs foreign-born) influence IBD manifestations, disease onset, treatments, and outcomes.

In this episode of IBD Drive Time, guest host Dr David Rubin and Dr Adjoa Anyane-Yeboa discuss how the social determinants of health--from race and income to government policies—affect the delivery of quality care to patients with...

Dr Rieder, from Cleveland Clinic, reviews his keynote address on diagnosing and treating stricturing Crohn's disease, including the use of medical, dilation, and surgical options.

Dr Cohen discusses with host Dr Raymond Cross the recent guidelines published by the American Gastroenterological Association on using biomarkers to monitor inflammatory bowel disease.

Dr Allegretti reviews the key points of her presentation on new live and microbiome-based therapeutics for recurrent Clostridioides difficile among patients with inflammatory bowel disease.

In this episode of IBD Drive Time, Dr Raymond Cross and Dr Russell Cohen review several new therapies and formulations that have been recently approved for treating inflammatory bowel disease and discuss how best to position these medications.

Dr Millie Long, one of the cochairs of the AIBD 2023 conference, reviews the challenges of positioning therapies for IBD, cautioning that there are no cut-and-dried answers and clinicians must consider the specific needs of each individual...

At AIBD 2023, Dr Rubin reviewed the history of combination therapy for inflammatory bowel disease and explored the potential of combining newer biologic and small molecule therapies to address the understand the immunological basis of IBD and...